AZNCX
Price
$9.72
Change
-$0.03 (-0.31%)
Updated
Jul 15 closing price
Net Assets
4.69B
RLBGX
Price
$36.76
Change
-$0.14 (-0.38%)
Updated
Jul 15 closing price
Net Assets
252.32B
Interact to see
Advertisement

AZNCX vs RLBGX

Header iconAZNCX vs RLBGX Comparison
Open Charts AZNCX vs RLBGXBanner chart's image
Virtus Income & Growth C
Price$9.72
Change-$0.03 (-0.31%)
VolumeN/A
Net Assets4.69B
American Funds American Balanced R6
Price$36.76
Change-$0.14 (-0.38%)
VolumeN/A
Net Assets252.32B
AZNCX vs RLBGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AZNCX vs. RLBGX commentary
Jul 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZNCX is a Buy and RLBGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBGX has more cash in the bank: 252B vs. AZNCX (4.69B). RLBGX (2.15) and AZNCX (2.06) have matching dividends . AZNCX was incepted earlier than RLBGX: AZNCX (18 years) vs RLBGX (16 years). AZNCX (1.90) is less costly to investors than RLBGX (0.25). AZNCX is a more actively managed with annual turnover of: 61.00 vs. RLBGX (44.00). RLBGX has a lower initial minimum investment than AZNCX: RLBGX (250) vs AZNCX (2500). RLBGX annual gain was more profitable for investors over the last year : 6.37 vs. AZNCX (1.81). RLBGX return over 5 years is better than : 40.60 vs. AZNCX (4.39).
AZNCXRLBGXAZNCX / RLBGX
Total Expense Ratio1.900.25760%
Annual Report Gross Expense Ratio1.900.25760%
Fund Existence18 years16 years-
Gain YTD1.8707.84924%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.69B252B2%
Annual Yield % from dividends2.062.1596%
Returns for 1 year1.816.3728%
Returns for 3 years11.8136.1733%
Returns for 5 years4.3940.6011%
Returns for 10 years0.5364.951%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCLI1.20N/A
N/A
Brainstorm Cell Therapeutics
SPCE3.16-0.05
-1.56%
Virgin Galactic Holdings
SIBN16.92-0.40
-2.31%
SI-BONE
BAH104.77-2.98
-2.77%
Booz Allen Hamilton Holding Corp
CRNX31.83-1.19
-3.60%
Crinetics Pharmaceuticals